Japanese Drugstore To Move Into Prescription Market

1 December 1997

Japan's largest drugstore, Matsumoto Kiyoshi, with 300 retail outlets,is to switch its main emphasis from general health consumer products to "the business of filling prescriptions" starting next year, according to its vice president, Namio Matsumoto.

The company believes that the government's policy to reduce medical spending will lead doctors to cut back on practice-based drug dispensing. At the same time, the Ministry of Health and Welfare is promoting a system in which patients will rely increasingly on local drugstores for their prescriptions.

Hospitals are currently handling about 8,000 billion yen ($63.04 billion) of drug prescriptions a year, but industry forecasts indicate that a considerable portion of this will be handled in future by drugstores. The Japanese drugstore sector quotes the example of the USA, where doctors issue prescriptions but are not allowed to dispense drugs directly and where drugstores dispense most of the scripts.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight